CAR T cell cancer immunotherapy, illustration

CAR T cell cancer immunotherapy, illustration

C038/7703 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 100.0MB

Downloadable file size: 11.8MB

Price image Pricing

Please login to use the price calculator


Caption: CAR T cell cancer immunotherapy. Illustration of the membrane of a cell involved in CAR (chimeric antigen receptor) T cell immunotherapy, a process that is being developed to treat cancer. In this process, T cells (part of the immune system) are treated with a virus in a form of genetic engineering, resulting in them producing chimeric antigen receptor (CAR) proteins. These proteins will be specific to the patient's cancer. Here, these engineered receptors (light blue, one at top right) bind specifically to CD19-antigen molecules (purple), in this case on a leukaemia cell. This activates a signal cascade in the T-cell leading to the segregation of vesicles that contain perforin and granzyme (yellow) molecules. The perforins build channels for the granzymes which enter the leukaemia cell and trigger the apoptosis (cell death) of the cancer cell.

Release details: Model release not required. Property release not required.

Keywords: anti-cancer, antibody, anticancer, antigen, antigens, apoptosis, artificial t-cell receptor, artwork, bioengineering, biological, biomedical, biomolecule, cancer, car, car t cell immunotherapy, car t-cell, car therapy, car-t, cd-19, cell, cell biology, cell membrane, cells, cellular, chimeric antigen receptor, chimeric immunoreceptor, chimeric t-cell receptor, cytokine, genetic, genetic engineering, genetically, genetics, gm, gmo, granzyme, illustration, immune system, immunological, immunology, immunotherapy, leukaemia, leukemia, living drug, lymphocyte, lymphocytes, medical, medicine, membrane receptor, modification, modified, modifying, no-one, nobody, perforin, protein, proteins, signal protein, t cells, t-cell, t-cell therapy, t-cells, therapy, treating, treatment, tumor specific, viral, virus, white blood cell, white blood cells

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.